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1  |  INTRODUC TION
Blood pressure (BP) is characterized by spontaneous fluctuations 
in both the short term ranging from seconds to hours and the long 
term ranging from days to years.1 BP variability (BPV) results from a 
complex interplay between intrinsic cardiovascular regulation mech-
anisms, including humoral and neural central or reflex influences, 
as well as extrinsic environmental and behavioral factors.2 BPV has 
been increasingly recognized as a prognostic marker of cardiovas-
cular disease (CVD), independent of mean BP.3 In particular, visit-
to-visit BPV, which is the intra-individual BP between office visits, 
reflects the long-term fluctuations in BP and the BP burden on the 
cardiovascular system.4 Contrary to previous notions about visit-
to-visit BPV as a random phenomenon, it is highly reproducible in 
clinical practice and has been known to have prognostic values for 
a wide range of health outcomes (eg, coronary heart disease, stroke, 
and all-cause mortality).5-7 Previous work revealed that visit-to-visit 
variability in systolic BP improved 8-year predictions of major CVD-
related health outcomes beyond those obtained from traditional risk 
factors.8
Sleep also plays an essential role in cardiovascular health. 
Abnormal sleep duration and poor quality (eg, low sleep efficiency 
and obstructive sleep apnea [OSA]) can contribute to disturbed BP 
control and cardiovascular risks, such as hypertension.9,10 Sleep 
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Abstract
Visit-to-visit blood pressure (BP) variability (BPV) is an independent risk factor of car-
diovascular disease (CVD). Sleep architecture characterizes the distribution of dif-
ferent stages of sleep and may be important in CVD development. We examined the 
association between visit-to-visit BPV and sleep architecture using in-lab polysom-
nographic data from 3,565 patients referred to an academic sleep center. BPV was 
calculated using the intra-individual coefficient of variation of BP measures collected 
12 months before the sleep study. We conducted multiple linear regression analy-
ses to assess the association of systolic and diastolic BPV with sleep architecture—
rapid eye movement (REM) and non-rapid eye movement (NREM) sleep duration.
Our results show that systolic BPV was inversely associated with REM sleep dura-
tion (p = .058). When patients were divided into tertile groups based on their BPV, 
those in the third tertile (highest variability) spent 2.7 fewer minutes in REM sleep 
than those in the first tertile (lowest variability, p = .032), after adjusting for covari-
ates. We did not find an association of systolic BPV with other measures of sleep 
architecture. Diastolic BPV was not associated with sleep architecture either. In sum-
mary, our study showed that greater systolic BPV was associated with lower REM 
sleep duration. Future investigation is warranted to clarify the directionality, mecha-
nism, and therapeutic implications.
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architecture is an objective measure of sleep quality assessed by 
polysomnography (PSG). This parameter characterizes the distri-
butions of different stages, and it can be broadly classified into 
two forms: rapid eye movement (REM) and non-rapid eye move-
ment including N1, N2, and N3 stages (collectively NREM).11 A 
limited number of studies have suggested possible implications 
of sleep architecture in CVD.12,13 Although visit-to-visit BPV and 
sleep architecture have each shown an individual link to cardiovas-
cular health, their relationship has not been explored. In addition, 
past research has primarily focused on short-term variations of BP 
occurring over 24 hours in the context of OSA, leaving evidence 
for long-term BPV relatively scarce.14 To address these gaps, our 
study examined the association between visit-to-visit BPV and 
sleep architecture.
2  |  MATERIAL S AND METHODS
2.1  |  Study sample and dataset
We reviewed in-lab PSG from patients who were referred to the 
Sleep Center at the University of Virginia Health System between 
2010 and 2017. Nearly all patients were referred to the sleep center 
for evaluation of sleep-disordered breathing.15,16 Objective sleep 
measures were extracted from the PSG reports. Patients’ health 
data, including demographic characteristics, vital signs (eg, BP meas-
urements), medical history (diabetes and hyperlipidemia), and history 
of medication use, were extracted from their electronic medical re-
cords and were subsequently linked to the PSG dataset. We included 
the patients who met the following criteria: 1) aged over 18 years, 
2) underwent a diagnostic PSG study, and 3) had at least three BP 
measures taken during office visits within one year prior to the sleep 
studies. Excluded were those who underwent split night studies, 
home sleep studies, or continuous positive airway pressure titration 
studies where sleep architecture variables were either not recorded 
or limited to only a small portion of the night. This study was ap-
proved by the University of Virginia Institutional Review Board.
2.2  |  Blood pressure and blood pressure variability
All available BP readings taken during any office visits within the 
University of Virginia Health System and recorded in patients’ elec-
tronic medical records were extracted. We used measurements 
taken one year before the sleep studies to calculate mean and intra-
individual standard deviation (SD). BP was measured with validated 
and regularly recalibrated Dinamap devices by registered nurses 
following standard guidelines throughout the University of Virginia 
Health System.17 The number of BP readings for each patient dur-
ing the year prior to the sleep study ranged between 3 and 146, 
with an average of 9.8 (median = 7; interquartile range = [4, 11]). For 
patients who had more than 12 measures taken during this period, 
12 measures were randomly selected and used to compute mean 
BP and BPV. Considering that mean and SD of BP measures are cor-
related, we used the coefficient of variation (defined as SD divided 
by the mean) as a measure of systolic BPV and diastolic BPV.4 These 
two indices were then grouped into tertiles of systolic BPV and dias-
tolic BPV, respectively.
2.3  |  Objective sleep measures
Overnight PSGs were performed using the standard channels 
recommended by the American Academy of Sleep Medicine. 
Raw data were processed with the Embla Sandman Elite soft-
ware (Natus Medical Incorporated, California, USA) and scored 
by registered PSG technologists. We employed the following 
objective sleep measures for analyses: total sleep time, sleep 
architecture, and apnea–hypopnea index (AHI). For the purpose 
of this study, sleep architecture was expressed as the duration 
of each sleep stage (REM and NREM [N1, N2 and N3]) (minutes) 
as well as their proportions relative to total sleep time (%). AHI, 
an index determining the severity of OSA, was derived from the 
number of apnea and hypopnea events per hour of sleep. We 
defined apnea as a reduction in airflow greater than 90% of the 
pre-event baseline and occurring for longer than 10 seconds 
using a thermocouple signal. Hypopnea events were recorded 
when the amplitude of the nasal pressure flow signal drop more 
than 30% of the pre-event baseline for longer than 10 seconds. 
We adopted a hypopnea definition requiring at least 4% oxygen 
desaturation (eg, Rule 1A for PSGs conducted between 2014 
and 2018 and Rule 4B for PSGs conducted between 2010 and 
2013).18,19 OSA was defined by AHI greater than 5 per hour of 
sleep and was further classified into four levels of severity: nor-
mal (< 5.0/h), mild (5.0 - 14.9/h), moderate (15.0 - 29.9/h), and 
severe (≥ 30.0/h).
2.4  |  Covariates
We selected the following variables from patients’ medical records 
as potential confounders: demographic and biometric characteris-
tics, mean systolic and diastolic BP, diabetes, hyperlipidemia, and 
use of medications including antipsychotics, antidepressants, and 
antihypertensives which could affect BP and/or sleep architec-
ture. Several cardiovascular risk factors including hypertension 
diagnosis, mean systolic BP, diabetes, hyperlipidemia, and obesity 
may be potential confounders in the relationship between sys-
tolic BPV and sleep architecture. They thus were identified and 
adjusted in multivariable models. Demographic and biometric vari-
ables included age, sex, race/ethnicity (non-Hispanic white, non-
Hispanic black, Hispanic, and other), and body mass index (BMI). 
BMI was calculated by height and weight and was then categorized 
into four groups (<25.0 kg/m2; 25.0-29.9 kg/m2; 30-34.9 kg/m2; 
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≥35.0 kg/m2). Information about the prescription of antipsychotic, 
antidepressant, and antihypertensive medications that are known 
to affect sleep was identified from medical records for the two 
years before the sleep studies. Patients were classified as users 
or non-users of antipsychotic and/or antidepressant medica-
tions. Because calcium channel blockers have been shown to re-
duce long-term BPV,20 we grouped patients into three categories 
of antihypertensive medication use: non-users, calcium channel 
blocker users, and users of other BP medications.
2.5  |  Statistical analysis
All statistical analyses were performed using Stata/SE version 15 
(StataCorp, College Station, TX, USA). We computed Pearson coeffi-
cients among all pairs of predictors in the preliminary analyses to ex-
amine potential collinearity among the predictors. We subsequently 
performed multicollinearity diagnostic and confirmed that our pre-
dictors all had variance inflation factor < 4 and did not raise multicol-
linearity concerns. The patients’ health data were compared among 
systolic BPV tertiles using analysis of variance or chi-square tests of 
independence. Multiple linear regression models were built to eval-
uate the cross-sectional association between visit-to-visit BPV and 
sleep architecture. We modeled measures of sleep architecture (N1, 
N2, N3, and REM sleep time) as a function of intra-individual sys-
tolic BPV and diastolic BPV, controlling for age, sex, race/ethnicity, 
BMI categories, diabetes, hyperlipidemia, history of medication use, 
mean systolic or diastolic BP, total sleep time, and AHI categories.
3  |  RESULTS
3.1  |  Sample characteristics
Table 1 summarizes patient demographics and biometric char-
acteristics stratified by systolic BPV tertiles. Our final sample 
consisted of 3,565 patients (1,353 males and 2,212 females, 
mean age of 54 ± 15 years). This was a racially and ethnically 
diverse cohort with 37% minorities. Over 91% of the sample was 
either overweight or obese, 36% had diabetes, and 51% had hy-
perlipidemia. The average BP of our sample was 132/76 mmHg. 
Patients with higher systolic BPV were more likely to have ad-
vanced age, higher diastolic BPV, higher AHI, and be users of 
antihypertensive and antipsychotic medications. Table 2 displays 
characteristics of sleep measures and architecture. The patients 
had an average total sleep time of 339.5 ± 88.2 minutes. As ex-
pected, OSA was common (73%) in our study sample (mean AHI 
was 16.5 ± 18.0/h). Higher systolic BPV was associated with 
higher AHI (p < .001). REM and NREM sleep accounted for about 
17% and 84% of total sleep time, respectively. Patients with 
higher systolic BPV tended to have shorter REM sleep duration 
(p < .001), longer N1 sleep percentage (p = .001), and shorter N2 
and N3 sleep durations.
3.2  |  Association of systolic BPV and diastolic BPV 
with sleep architecture
In unadjusted analyses, systolic BP and diastolic BP coefficients 
of variation were correlated with REM sleep duration at r = −.091 
(p < .001) and −0.085 (p < .001), respectively. There was an inverse 
association between systolic BPV and REM sleep duration (β = −22.2, 
p = .058), independent of patient demographic and biometric char-
acteristics, diabetes, hyperlipidemia, mean systolic BP, medication 
use, total sleep time, and AHI (Model 1, Table 3). In Model 2 where 
systolic BPV tertile was a main predictor, patients in tertile 3 (highest 
variability) spent about 2.7 fewer minutes in REM sleep compared 
to those in tertile 1 (lowest variability) (p = .032). This difference 
represented nearly 5% of the total REM sleep duration in this cohort. 
On the other hand, diastolic BPV did not show any association with 
REM sleep duration. Even though patients in the higher tertiles of 
diastolic BPV demonstrated shorter REM sleep duration, no signifi-
cant difference was found between tertiles 1 and 3 (Models 1 and 2, 
Table 3). No associations were found between BPV and any NREM 
sleep durations.
4  |  DISCUSSION
We found that systolic visit-to-visit BPV had an inverse association 
with REM sleep duration, independent of potential confounders in-
cluding other sleep characteristics (total sleep time and OSA). When 
systolic BPV was divided into tertiles, patients with the highest vari-
ability (tertile 3) spent about 2.7 fewer minutes in REM sleep than 
those with the lowest variability (tertile 1). In contrast, no associa-
tion was found between BPV and NREM sleep. To the best of our 
knowledge, this represents the first study to investigate the associa-
tion between long-term BPV and sleep architecture.
BP is a major health factor essential for cardiovascular health, 
and managing BP is one of the seven recommended health be-
haviors included in the American Heart Association's Life's Simple 
7.21,22 Our findings were in accordance with prior study results 
demonstrating the importance of maintaining BP stability.23 
Growing evidence suggests that visit-to-visit BPV has import-
ant prognostic values for CVD and many other adverse health 
outcomes.24-26 Of note, this parameter has demonstrated a 
comparable CVD prognosis to the 24-hour ambulatory BPV. A me-
ta-analysis presented hazard ratios for all-cause mortality among 
three systolic BPV indices (visit-to-visit: 1.12 [1.05-1.20]; day-to-
day: 1.15 [1.06-1.26]; 24-hour ambulatory: 1.11 [1.04-1.18]), with 
visit-to-visit BPV manifesting a similar strong association with car-
diovascular and mortality outcomes in comparison with the other 
two indices.27 Recently, several studies have proposed potential 
mechanisms by which BPV links to cardiovascular risks, such as 
large arterial stiffness, endothelial dysfunction, sympathetic over-
activity, and autonomic imbalance.2,28,29 Although poor sleep as 
an established CVD risk factor is linked to altered BP responses 
(eg, hypertension, nocturnal non-dipping BP), how BPV might be 
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TA B L E  1  Demographic and biometric characteristics of the sample
Variable
Systolic BPV Tertiles
All 1 2 3
p-ValueN (%) N (%) N (%) N (%)
All, n (Row %) 3,565 (100.0%) 1,170 (32.82%) 1,198 (33.60%) 1,197 (33.58%)
Intra-individual Systolic BP, mean (SD)




13.89 (6.40) 7.80 (2.36) 12.99 (1.99) 20.75 (5.35) <.001
Coefficient of 
Variation
0.10 (0.04) 0.06 (0.02) 0.10 (0.01) 0.15 (0.03) <.001
Maximum (mm 
Hg)
152.26 (21.69) 139.39 (14.87) 150.07 (17.70) 167.03 (22.08) <.001
Minimum (mm 
Hg)
113.44 (14.70) 119.21 (13.29) 113.03 (14.00) 108.22 (14.66) <.001
Number of 
Measures
7.45 (3.39) 6.12 (3.04) 8.06 (3.32) 8.14 (3.42) <.001
Intra-individual Diastolic BP, mean (SD)




8.39 (3.55) 7.06 (3.13) 8.02 (3.06) 10.06 (3.73) <.001
Coefficient of 
Variation
0.11 (0.05) 0.09 (0.04) 0.11 (0.04) 0.13 (0.05) <.001
Maximum (mm 
Hg)
87.39 (11.11) 84.33 (9.95) 86.90 (10.64) 90.86 (11.67) <.001
Minimum (mm 
Hg)
64.05 (10.06) 66.31 (9.38) 63.89 (9.72) 62.00 (10.57) <.001
Number of 
Measures
7.45 (3.39) 6.12 (3.04) 8.06 (3.32) 8.14 (3.42) <.001
Age at Time of 
Sleep Study, 
mean (SD)
54.17 (14.66) 51.94 (14.66) 53.90 (14.94) 56.61 (14.01) <.001




2,238 (62.78%) 759 (64.87%) 753 (62.85%) 726 (60.65%) .019
Non-Hispanic 
Black
862 (24.18%) 259 (22.14%) 290 (24.21%) 313 (26.15%)
Hispanic 119 (3.34%) 40 (3.42%) 51 (4.26%) 28 (2.34%)
Other/Unknown 346 (9.71%) 112 (9.57%) 104 (8.68%) 130 (10.86%)
BMI (kg/m2), mean 
(SD)
35.45 (8.89) 35.26 (8.63) 34.85 (8.57) 36.24 (9.37) <.001
BMI Categories
<25 311 (8.72%) 96 (8.21%) 118 (9.85%) 97 (8.10%) .216
25-29.9 743 (20.84%) 256 (21.88%) 247 (20.62%) 240 (20.05%)
30-34.9 848 (23.79%) 280 (23.93%) 299 (24.96%) 269 (22.47%)
≥35 1,663 (46.65%) 538 (45.98%) 534 (44.57%) 591 (49.37%)
Diabetes 1,283 (35.99%) 316 (27.01%) 417 (34.81%) 550 (45.95%) <.001
Hyperlipidemia 1,805 (50.63%) 477 (40.77%) 610 (50.92%) 718 (59.98%) <.001
(Continues)
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related to sleep has not been sufficiently explored.30 Existing stud-
ies were mainly focused on the association of BPV with sleep-dis-
ordered breathing, suggesting the possible contribution of OSA to 
increased visit-to-visit BPV.31,32 In this context, we hypothesized 
that increased visit-to-visit BPV, an indicator of subclinical CVD, 
could be associated with poor sleep quality independent of OSA.
REM sleep is a distinct sleep stage that encompasses several phys-
iological and behavioral features, such as muscle atonia, intermittent 
muscle twitches, and autonomic and respiratory activation.33 REM 
sleep that constitutes about 20% of total sleep time is considered 
high quality of sleep in adults.34 Lower REM percentage (16.6% of 
total sleep time) in our study cohort is likely attributed to high prev-
alence of OSA, which typically results in sleep fragmentation and 
reduction in REM or N3 duration as shown in this study.35 Moreover, 
since REM occurs more toward late stage in sleep, shorter sleep time 
expected in an in-lab environment would be associated with reduced 
REM percentage and REM duration. As such, our findings may be 
more relevant in patients with OSA.
Variable
Systolic BPV Tertiles
All 1 2 3
p-ValueN (%) N (%) N (%) N (%)
Antihypertensive Use, N (%)
No Medication 1,307 (36.66%) 562 (48.03%) 444 (37.06%) 301 (25.15%) <.001
Calcium Channel 
Blocker
805 (22.58%) 177 (15.13%) 273 (22.79%) 355 (29.66%)
Other BP 
Medications
1,453 (40.76%) 431 (36.84%) 481 (40.15%) 541 (45.20%)
Antipsychotic Use, 
mean (SD)
366 10.27% 93 7.95% 121 10.10% 152 12.70% <.001
Antidepressant 
Use, mean (SD)
1,053 29.54% 292 24.96% 379 31.64% 382 31.91% <.001
Abbreviations: AHI, apnea–hypopnea index; BMI, body mass index; BP, blood pressure; BPV, blood pressure variability; REM, rapid eye movement; 
SD, standard deviation.
TA B L E  1  (Continued)
TA B L E  2  Characteristics of sleep variables across systolic BPV tertiles
Variable
Systolic BPV Tertiles
All 1 2 3 p-Value
Total Sleep Time (min), mean (SD) 339.50 (88.20) 344.69 (84.75) 342.05 (85.49) 331.87 (93.57) <.001
AHI, mean (SD) 16.50 (18.00) 15.11 (16.75) 16.16 (17.14) 18.21 (19.81) <.001
AHI Categories, N (%)
<5 950 (26.65%) 344 (29.40%) 316 (6.38%) 290 (24.23%) .009
5-14.9 1,238 (34.73%) 419 (35.81%) 412 (34.39%) 407 (34.00%)
15-29.9 843 (23.65%) 256 (21.88%) 295 (24.62%) 292 (24.39%)
≥30 534 (14.98%) 151 (12.91%) 175 (14.61%) 208 (17.38%)
REM Percentage, mean (SD) 16.57 (9.06) 17.43 (9.08) 16.67 (9.12) 15.61 (8.88) <.001
NREM Percentage, mean (SD)
N1 9.46 (10.28) 8.75 (8.88) 9.35 (9.93) 10.27 (11.74) .001
N2 63.12 (13.31) 62.81 (12.56) 62.89 (13.48) 63.66 (13.84) .228
N3 12.34 (14.22) 12.90 (14.11) 12.29 (13.4) 11.85 (15.08) .194
REM Duration (min), mean (SD) 58.94 (37.03) 62.99 (38.42) 59.13 (36.52) 54.81 (35.72) <.001
NREM Duration (min), mean (SD)
N1 28.41 (25.87) 27.04 (23.35) 28.71 (26.82) 29.47 (27.18) .066
N2 214.88 (71.40) 216.69 (66.57) 215.64 (71.20) 212.35 (76.00) .302
N3 42.90 (52.78) 45.24 (52.4) 42.93 (48.04) 40.58 (57.42) .099
Abbreviations: AHI, apnea–hypopnea index; BPV, blood pressure variability; NREM, non-rapid eye movement; REM, rapid eye movement; SD, 
standard deviation.
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Current investigations on REM sleep are mostly centered in 
the field of behavioral science. There is wide acknowledgment of 
the essential roles of this sleep stage in emotional regulation and 
memory consolidation.36 While the other functions of this sleep 
stage remain unclear, maintaining REM sleep homeostasis is critical 
and may be important in cardiovascular health. A few studies have 
demonstrated that REM sleep-associated OSA is independently 
related to CVD, such as hypertension, impaired glucose metabo-
lism, and cardiovascular end points,37,38 but the role of REM sleep 
itself in cardiovascular health is quite limited. Pace et al39 recently 
found that REM sleep duration was significantly reduced during the 
first 24 hours following stroke events in animals and that increased 
REM latency was linked to poor functional outcomes among post-
stroke patients. Another study reported that one SD of decrease 
in REM sleep percentage was associated with an 18% increase in 
risk for atrial fibrillation, after controlling for covariates including 
OSA.12 Our study results were consistent with the literature, sup-
porting the growing body of evidence that linked sleep architecture 
to cardiovascular health. Although the absolute difference in REM 
sleep duration across visit-to-visit BPV tertiles was small and is of 
uncertain clinical significance, some clinical implications can be pos-
tulated. For example, if a patient undergoing routine PSG for OSA 
evaluation exhibits a significant deviation of REM sleep duration 
(such as absence or scarcity of REM sleep), a clinician may consider 
evaluating the patient's BP control, specifically BPV. Conversely, for 
patients with increased BPV (eg, the SD of systolic BP greater than 
10 mmHg),5 a clinician may consider impaired sleep quality as a pos-
sible factor.
Despite the intriguing study findings, our results require careful 
interpretations. Given the cross-sectional nature of this study, it is 
important to emphasize that this study only presents a potential in-
terplay between visit-to-visit BPV and REM sleep rather than infer-
ring causality, as their relationship can go in either or both directions. 
The impact of cardiovascular dysfunction on objective sleep quality 
has not been previously examined. Thus, in this study, we were moti-
vated to examine whether BPV, a signature of autonomic dysregula-
tion of cardiovascular system,40,41 predicts poor sleep architecture.
The strengths of this study include using a large sample and ob-
jective PSG data. Despite these strengths, several limitations should 
be noted. First, the results derived from a single-night, lab-based 
PSG may not represent the patients’ natural sleep patterns because 
the unique assessment environment may distort their usual sleep 
habits. Second, since the cohort consisted of patients referred for 
sleep studies in one single institution, generalizability of the study 
findings is limited. Thus, a sample collected from multiple institu-
tions is needed for more generalizable results. Third, medication use 
was obtained from prescriptions on medical records and may not 
represent actual use.
5  |  CONCLUSION
In this study, we found that higher visit-to-visit BPV was associated 
with sleep architecture as reflected by reduced REM sleep duration. 
The potential pathway linking long-term BPV and sleep warrants 
future studies to clarify the directionality, mechanisms, and thera-
peutic implications. Such research studies may provide insights on 
stratifying individuals at high risk of CVD and developing targeted 
clinical interventions to reduce BP fluctuations and address sleep 
problems.
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TA B L E  3  Multiple linear regression of BPV (Model 1) and BPV tertiles (Model 2) on REM sleep duration
Variable
Model 1 Model 2
Estimate (95% CI) p-Value Estimate (95% CI) p-Value
Systolic Blood Pressure Variability
Coefficient of Variation -22.188 (−0.045, 0.737) .058
Tertiles [1 (Lowest Variability)]
2 -2.251 (−0.005 0.135) .064
3 (Highest Variability) -2.700 (−0.005 -0.239) .032
Diastolic Blood Pressure Variability
Coefficient of Variation -13.560 (−0.034, 7.195) .200
Tertiles [1 (Lowest Variability)]
2 -0.468 (−0.003 1.905) .699
3 (Highest Variability) -1.761 (−0.004 0.658) .154
Note: Reference categories are in angle brackets. The models were adjusted for age, sex, race/ethnicity, BMI, diabetes, hyperlipidemia, total sleep 
time, mean systolic BP, AHI, antipsychotic or antidepressant medication use, and antihypertensive medication use.
Abbreviations: BPV, blood pressure variability; CI, confidence interval.
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